Allurion to raise approximately $7.4 million of gross proceeds in offering priced at-the-market

Natick, mass.--(business wire)--allurion technologies, inc. (“allurion” or the “company”) (nyse: alur), a company dedicated to ending obesity, today announced that it has entered into a definitive securities purchase agreement with certain institutional investors for the purchase and sale of 1,240,000 shares of the company's common stock at a price of $6.00 per share in a registered direct offering priced at-the-market under nyse rules. in addition, in a concurrent private placement, the compan.
ALUR Ratings Summary
ALUR Quant Ranking